×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Speakers :

Prof. Christina Fotopoulou, United Kingdom
Prof. Jean-Marc Classe, France
Dr. Philipp Harter, Germany

Prof. Isabelle Ray-Coquard, France

Program


18:00 Primary surgery or interval surgery : TRUST trial
Prof. Christina Fotopoulou
 
18:15 Interval surgery after ¾ cycles or delayed surgery after 6 cycles : CHRONO trial
Prof. Jean-Marc Classe
 
18:30 Surgery for the first relapse : DESKTOP trial
Dr. Philipp Harter
 
18:45 PARP inhibitors, bevacizumab : PAOLA trial
Prof. Isabelle Ray-Coquard
 
19:00 Discussion and Q&A session
 
Shooting date : 2022-12-13
Last update : 2022-12-14

Suggestions

Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, April 12th 2022 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, April 12th 2022 from 09am to 10:30am (GMT-7)
New York : Tuesday, April 12th 2022 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT-3)
Reykjavik : Tuesday, April 12th 2022 from 04pm to 05:30pm (GMT)
London / Dublin : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, April 12th 2022 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, April 13th 2022 from 03am to 04:30am (GMT+11)
Wellington : Wednesday, April 13th 2022 from 05am to 06:30am (GMT+13)

Cancers séreux de bas grade

Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT-8)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT-5)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT-3)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+10)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+12)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT-7)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT-3)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+11)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+13)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT-10)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT-8)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+8)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+9)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+10)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+12)

Toxicités hématologiques des inhibiteurs de PARP

Regards croisés oncologue-hématologue-interniste

Share
Scroll Up